Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-21-024291
Filing Date
2021-06-16
Accepted
2021-06-16 19:40:48
Documents
2
Period of Report
2021-06-16

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 8085
2 EX-24.1 DOCUMENT attachment1.htm EX-24.1 4735
  Complete submission text file 0000899243-21-024291.txt   14186
Mailing Address C/O GOOGLE VENTURES 2011, L.P. 1600 AMPHITHEATRE PARKWAY MOUNTAIN VIEW CA 94043
Business Address
Yeshwant Krishna (Reporting) CIK: 0001585001 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40489 | Film No.: 211022934

Mailing Address 500 TECHNOLOGY SQUARE CAMBRIDGE MA 02139
Business Address 500 TECHNOLOGY SQUARE CAMBRIDGE MA 02139 (978) 501-3026
Verve Therapeutics, Inc. (Issuer) CIK: 0001840574 (see all company filings)

EIN.: 824800132 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations